← All trials
NCT06062953
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 18, 2023
- Primary completion
- Feb 28, 2026
- Completion date
- Feb 28, 2026
- First posted
- Oct 2, 2023
- Last posted
- Oct 2, 2023
- Enrollment
- 255
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of CopenhagenLead sponsor
- Mental Health Services in the Capital Region, DenmarkCollaborator
- University of CopenhagenCollaborator
- University of CopenhagenOverall official - principal investigator
- University of CopenhagenSponsor investigator
- Danish Center for Sleep MedicineCollaborator
- Government of DenmarkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.